series-b
Stage
3
Investors
About
Reapplix develops personalized wound healing technology called the 3C Patch®, an autologous blood-derived patch that accelerates healing of hard-to-heal diabetic foot ulcers.
Explore Reapplix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.